McCaffery T D, Kraft S C, Rothberg R M
Clin Exp Immunol. 1972 Jun;11(2):225-34.
Sera from 760 subjects with and without inflammatory bowel disease (IBD) were studied selectively using both primary and secondary antibody assay techniques and different cow's milk antigens. Techniques which demonstrate antibody–antigen binding revealed that the incidence, amount and immunoglobulin class of detectable antibody to bovine serum albumin (BSA) were not significantly different among IBD and control subjects. Only 13 of the 138 sera with the most anti-BSA by primary binding techniques had the capacity to precipitate spontaneously either BSA or antigens in raw (RSM) and pasteurized (PSM) skimmed milk. In passive haemagglutination studies, 41% of these 138 sera had the capacity to agglutinate BSA-coated erythrocytes, while the respective figures for RSM and PSM were 56% and 77%. Only in studies employing the passive haemagglutination of RSM-coated erythrocytes were high titres found more frequently in sera from patients with IBD than in sera from control subjects. Taken as a whole, this study fails to provide evidence for the pathogenetic significance of milk antibodies in IBD.
使用一级和二级抗体检测技术以及不同的牛奶抗原,对760名患有和未患有炎症性肠病(IBD)的受试者的血清进行了选择性研究。证明抗体 - 抗原结合的技术显示,IBD患者和对照受试者中可检测到的抗牛血清白蛋白(BSA)抗体的发生率、数量和免疫球蛋白类别没有显著差异。在通过一级结合技术检测到的抗BSA最多的138份血清中,只有13份能够自发沉淀生脱脂牛奶(RSM)和巴氏杀菌脱脂牛奶(PSM)中的BSA或抗原。在被动血凝试验研究中,这138份血清中有41%能够凝集包被BSA的红细胞,而RSM和PSM的相应比例分别为56%和77%。只有在采用包被RSM的红细胞进行被动血凝试验的研究中,IBD患者血清中的高滴度抗体比对照受试者血清中更常见。总体而言,这项研究未能提供牛奶抗体在IBD发病机制中的重要性的证据。